Rapid Micro Biosystems receives follow-on multi-system Growth Direct order from Samsung Biologics
Reuters
Mar 12
<a href="https://laohu8.com/S/RPID">Rapid Micro Biosystems</a> receives follow-on multi-system Growth Direct order from Samsung Biologics
Rapid Micro Biosystems announced a follow-on multi-system order from Samsung Biologics for its Growth Direct platform. The order expands Samsung Biologics’ deployment of the Growth Direct platform to automate microbial quality control across its manufacturing network. Rapid Micro Biosystems CEO Robert Spignesi said the platform is intended to support faster time to results and data integrity.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Micro Biosystems Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603120630PRIMZONEFULLFEED9670658) on March 12, 2026, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.